Innovative medicines: new regulatory procedures for the third millennium

被引：4
|
作者：
Rasi, Guido [1 ,2 ]
Bonini, Sergio [1 ,3 ,4 ]
机构：
[1] EMA, London, England
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Univ Naples 2, Rome, Italy
[4] Italian Natl Res Council CNR, Rome, Italy
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2015年 / 15卷
基金：
欧盟地平线“2020”;
关键词：
adaptive licensing; clinical trials; European Medicines Agency; health technology assessment; innovative medicines; transparency;
D O I：
10.1517/14712598.2015.1026322
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Despite tremendous progress in science and increasing investment in research and development, patients' access to innovative medicines remains limited. This is in part due to increasing regulatory requirements for product authorisation and cost-constrained national health systems. At the European Medicines Agency (EMA), we have tried to address these constraints by adapting our organisation and activities to changing business models, new technologies, and the current and emerging health needs in Europe. The main EMA initiatives to provide patients with effective, safe and affordable medicines are reviewed.
引用
收藏
页码：S5 / S8
页数：4
相关论文
共 50 条
  • [1] The Innovative Medicines Initiative: an engine for regulatory science
    Michel Goldman
    Nathalie Seigneuret
    Hans-Georg Eichler
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 1 - 2
  • [2] The Innovative Medicines Initiative: an engine for regulatory science
    Goldman, Michel
    Seigneuret, Nathalie
    Eichler, Hans-Georg
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 1 - 2
  • [3] Cyclodextrins: Emerging Medicines of the New Millennium
    Braga, Susana Santos
    [J]. BIOMOLECULES, 2019, 9 (12)
  • [4] New materials for the third millennium
    Yakobson, BI
    Smalley, RE
    [J]. RECHERCHE, 1998, (307): : 50 - 56
  • [5] The Regulatory Environment for the New Millennium
    Steven F. Hoff
    [J]. Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 659 - 672
  • [6] The regulatory environment for the new millennium
    Hoff, SF
    [J]. DRUG INFORMATION JOURNAL, 2000, 34 (03): : 659 - 672
  • [7] Biology-materials interface innovative technologies for the third millennium
    Natarajan, KA
    [J]. MATERIALS FOR THE THIRD MILLENNIUM, 2001, : 385 - 401
  • [8] Medicines for the millennium?
    Jones, RD
    Taylor, PM
    [J]. EQUINE VETERINARY EDUCATION, 1998, 10 (06) : 328 - 333
  • [9] Xenotransplantation: New perspectives for the third millennium
    Mosca, F
    [J]. ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 2003, 31 (02): : 145 - 148
  • [10] The new Liberalism: Faith for the Third Millennium
    Hudson, WD
    [J]. EXPOSITORY TIMES, 1998, 109 (11): : 350 - 350
12345